iBody Inc.

Antibodies play a critical role in the diagnosis and treatment of cancer, autoimmune diseases, infectious diseases, and more. Yet finding high-performance antibodies for specific applications remains a major challenge.
iBody’s proprietary technologies enable the rapid discovery of high-performance monoclonal antibodies that are difficult to obtain through conventional approaches. By overcoming this bottleneck, we accelerate the development of new therapeutics and diagnostics.